RECRUITING

SNS and PrEP Initiation and Adherence in Black SMM

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Specific Aim 1. Conduct 18 focus groups among Black gay, bisexual and other sexual minority men (SMM; n=72-90) in the Washington, DC area of different age groups (18-24, 25-34, 35+) and various pre-exposure prophylaxis (PrEP) use profiles (i.e., PrEP naïve, current PrEP users, and discontinued PrEP; two per age-group and PrEP use profile) to understand intervention feasibility, acceptability and appropriateness, how the intervention can address experienced and perceived socio-structural barriers, and increase PrEP initiation and adherence among Black SMM in the Washington, District of Columbia (DC) area. Specific Aim 2. Implement an iterative open-phase pilot of an SNS intervention to increase PrEP initiation among human immunodeficiency virus (HIV)-negative Black SMM, aged 18 years and above, in the Washington, DC area. Recruit 30 PrEP-using Black SMM, including those who use substances, as Recruiters to identify and refer Network Associates to PrEP services. The pilot will occur in six blocks of up to 5 Recruiters to further develop all intervention procedures and enhance the social networking strategy (SNS) intervention's feasibility and acceptability.

Official Title

PrEP Initiation and Adherence Among Black SMM: A Social Network-Level Intervention

Quick Facts

Study Start:2022-03-01
Study Completion:2023-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05499962

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age of 18 years or above
  2. * Black or African American race
  3. * Cisgender male identity
  4. * Gay, bisexual or a male who has sex with other males
  5. * Residence in the greater Washington, DC area (includes District of Columbia, Prince George's County, MD and Montgomery County, MD)
  6. * Current PrEP use
  7. * Confirmed HIV-negative status.
  1. * Being younger than 18 years of age ;
  2. * Cisgender or transgender female identity
  3. * Males having sex with women exclusively
  4. * Being unable to speak or read English
  5. * Reside outside of the defined greater Washington, DC area
  6. * Being unable or unwilling to provide written informed consent
  7. * Being unable to comply with the requirements of the protocol (e.g. persons with mental health conditions, persons who are intoxicated or incoherent for other reasons)
  8. * Being a member of other vulnerable populations: pregnant women, children or wards of the state.

Contacts and Locations

Study Contact

DeMarc A Hickson, PhD
CONTACT
678.613.9827
dhickson@uhupil.org
Adedotun Ogunbajo, PhD
CONTACT
202.446.1100
aogunbajo@uhupil.org

Principal Investigator

DeMarc A Hickson, PhD
PRINCIPAL_INVESTIGATOR
Executive Director

Study Locations (Sites)

Us Helping Us, People Into Living, Inc.
Washington, District of Columbia, 20010-1646
United States

Collaborators and Investigators

Sponsor: Us Helping Us, People Into Living, Inc.

  • DeMarc A Hickson, PhD, PRINCIPAL_INVESTIGATOR, Executive Director

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-01
Study Completion Date2023-12

Study Record Updates

Study Start Date2022-03-01
Study Completion Date2023-12

Terms related to this study

Additional Relevant MeSH Terms

  • HIV